The Biotechnology and Life Sciences group discuss CRISPR with Biotech and Money

Patent Attorney Edward Ronan and Trainee Patent Attorney Nadia Tyler-Rubinstein cover the latest developments in the case against CRISPR with Biotech and Money magazine. The recent decision on this case highlights the importance of robust IP practices in the early stages of protecting your technology, even more so where IP requirements may differ between countries.

Read their coverage here.